This message contains images. If you don't see images, click here to view.
  Mobile version   RSS   Subscribe   Unsubscribe
Home   Membership   Events   Resources   Accreditation March 10, 2010
Cystoscopy alone most cost-effective method to detect bladder cancer recurrence
HemOncToday    Share   Share on FacebookTwitterShare on
LinkedinE-mail article
After the evaluation of five bladder cancer surveillance strategies in a prospective trial, researchers have concluded that the use of cystoscopy alone was the most cost-effective strategy to discover recurrence. The cost per tumor detected was $7,692 for cystoscopy alone, followed by cystoscopy with nuclear matrix protein 22 confirmed by fluorescence in situ hybridization ($9,557), cystoscopy plus cytology ($10,267), cystoscopy plus NMP22 ($11,143) and cystoscopy plus FISH ($19,111). More

Balancing radiation risks, benefits, quality
HealthLeaders Media    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Medical imaging equipment such as X-rays, computed tomography and magnetic resonance imaging typically have played important roles in providing quality health by quickly and quietly detecting problems ranging from brain tumors to aneurysms. Furthermore, radiation therapy has become important in providing high-quality cancer care. But recent studies linking radiation overexposure for various reasons to cancer risks, illness and even death may be the start of a new era in the diagnostic and therapeutic uses of radiation. More

Inadequate regulation puts patients at risk
St. Louis Post-Dispatch    Share    Share on FacebookTwitterShare on LinkedinE-mail article
It's the kind of thing that never should happen but did. Seventy-six patients at a Springfield, Mo., health center received radiation overdoses while being treated for head and neck tumors. On average, they got 50 percent more radiation than had been prescribed. More

Study: Freezing malignant breast tumors helps stop the spread of cancer in mice
NY Daily News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Freezing a malignant tumor not only kills it, but it also may stop the cancer from spreading, according to new research on mice. The study, from the University of Michigan Comprehensive Cancer Center, described two different cryoablation techniques, ScienceDaily reports. More

Test may cut unneeded prostate biopsies
WebMD Health News    Share    Share on
FacebookTwitterShare on LinkedinE-mail article
A new urine test may reduce unnecessary biopsies for prostate cancer. The test, which is approved in some European countries but not in the U.S., detects RNA from prostate cancer gene 3. At a news briefing held in advance of the 2010 Genitourinary Cancers Symposium, researchers presented results of the largest study to date of the PCA3 test. More

Certain bone drugs may lower breast cancer risk
HealthDay News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Some types of bone-building drugs used to prevent and treat osteoporosis might reduce the risk of breast cancer, according to new research. The study, which included 6,000 Wisconsin women ages 20 to 69, found that those who took bisphosphonate drugs such as Fosamax, Boniva and Zometa for more than two years were 40 percent less likely to develop breast cancer than were women who did not take the drugs. However, the protective effective was seen only among women who were not obese. More

Radiation Oncology Consulting
Churchill Consulting, Inc., providing expert products and services since 1992. Premier product is DIRECTREES® (coding help application). Services include comprehensive chart audits, coding seminars, compliance programs, and QA Programs. MORE

Study: Lung cancer risk increases with HRT
Toronto Sun    Share    Share
on FacebookTwitterShare on LinkedinE-mail article
Hormone replacement therapy has been linked to an increase in lung cancer in a new U.S.-based study. Results from the study indicated a 50 percent increased risk of lung cancer in women who underwent a combined estrogen and progestin treatment for 10 years or longer. Those who only underwent estrogen therapy showed no extra risk. The study involved 36,588 peri- and post-menopausal women ages 50 to 76 from Washington state. Data were adjusted for smoking, age and other potential outside risks for lung cancer. More

Radiation most effective soon after breast cancer surgery
HealthDay News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
For women who have had breast cancer surgery, the question of whether or not to wait before receiving radiation therapy has been answered by new research that suggests that the longer women wait, the greater the chance of cancer recurrence. The findings, published in the March 3 online edition of BMJ, are based on an analysis of national cancer records for 18,050 American women who were diagnosed with early-stage breast cancer between 1991 and 2002, at age 65 or older. More

For breast cancer treatment that causes joint pain, acupuncture may help
Los Angeles Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Joint pain is a common side effect for women being treated with aromatase inhibitors for breast cancer. The treatment halts estrogen production in post-menopausal women, which means less of the hormone can fuel certain breast cancer cell growth. While women often remedy the discomfort with painkillers, researchers wondered if acupuncture might also help. More

Education should accompany prostate screening, new guidelines say
Los Angeles Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The American Cancer Society says doctors should tell their patients about the test's risks and benefits before administering it. New guidelines for prostate cancer screening issued March 3 emphasize that physicians should better educate men about both the risks and benefits of using the PSA test for screening. They also call for cutbacks in the use of digital rectal exams to find tumors and recommend the end of mass prostate-screening programs at health fairs and other sites. More
RadOnc Weekly
Ben Maitland, Director of Advertising Sales, 972.402.7025   Download media kit
Patrick McCoy, Content Editor, 469.420.2603   Contribute news
This edition of RadOnc Weekly was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
March 3, 2010
Feb. 24, 2010
Feb. 17, 2010
Feb. 10, 2010

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063